Optimal Antiplatelet Regimen in “Bi-Risk” ACS?
Among "bi-risk" patients with acute coronary syndrome (ACS) who received a stent and completed 9-12 months of dual antiplatelet therapy ...
Among "bi-risk" patients with acute coronary syndrome (ACS) who received a stent and completed 9-12 months of dual antiplatelet therapy ...
New European Society of Cardiology (ESC) guidelines on the management of acute coronary syndromes (ACS) have for the first time ...
Dual antiplatelet therapy (DAPT) consisting of aspirin plus a P2Y12 inhibitor has been the standard of care to prevent thrombotic ...
Replacing dual-antiplatelet therapy (DAPT) with clopidogrel alone 1 month after percutaneous intervention (PCI) offers a lower risk of bleeding with ...
© Pharma News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Pharma News Hubb All rights reserved.